News
Jesús García-Foncillas: “Only one in ten ‘first in human’ trials works, but we have to keep trying”
The researcher Jesus Garcia Foncillas has recently joined the Institute of Health Research ‘Fundación Jiménez Díaz’ as director of the Cancer Research Unit. There he continues his research in the field of microRNA, how they control the expression of genes and how they can be useful in clinic. He explained his progress in the seminar […]
IDIBELL expresses its condolences for the death of the artist Antoni Tapies
The Institute of Bellvitge Biomedical Research (IDIBELL) wishes to express its condolences for the death of Antoni Tàpies on February 6th. In 2005 the artist made in an altruistic way the logo of the research centre, in the same way that years before had made the logo of the Foundation August Pi i Sunyer of […]
Science vs Cancer
Saturday 4 February is World Cancer Day. This disease is a leading cause of death worldwide. The World Health Organization (WHO) estimates that, without any intervention, 84 million people will die of cancer between 2005 and 2015. The RNE program “En días como hoy”, directed and presented by journalist Juan Ramón Lucas, held a colloquium […]
Francesc Posas: “Basic research allows designing more accurate clinical applications”
“Understanding how cells respond to stress, how they realize that there is a dangerous situation and how they put in place the mechanisms to respond.” This is one of the objectives of the laboratory run by Francesc Posas in the Universitat Pompeu Fabra. More specifically, study the functions of these kinases in stress response mechanisms. […]
Emilià Pola: ”2011 has been the best year of IDIBELL, at the worst economic period”
With this sentence the general director of IDIBELL, Emilià Pola, has summarized the general situation of the institution: our scientific production has increased, and also our impact, and we have more competitive projects. On the other side of the scales, the economic crisis means that there is less support and less amount, and it complicates […]
Manel Esteller, I National Award in Cancer Research ‘Doctores Diz Pintado’
The director of the Cancer Epigenetics and Biology program at IDIBELL and professor of the University of Barcelona, Manel Esteller, has won the ‘I National Award for Research on Cancer Doctores Diz Pintado’ for his scientific career, awarded by the Cancer Research Foundation of the University of Salamanca (Ficus). The award was granted to Esteller […]
Pedro Montoya: “Chronic pain not only hurts, it also damages the brain”
The researcher Peter Montoya and his team at the University of the Balearic Islands are investigating how brain function changes in patients with chronic pain compared with brain activity in healthy subjects. He explained his latest results on 20 January in the series of seminars IDIBELL. “We do not know how the fire occurs; we […]
Anna Veiga: ”We need very safe iPS cells if we want to use them in the clinic”
The researcher of the Center for Regenerative Medicine in Barcelona, CMR[B], Anna Veiga, explained the latest developments of her research group on “in vitro” models of pluripotency in embryonic stem cells (hESCs) and iPS cells ( induced pluripotent stem cells). It was on January 13 in the cycle of seminars IDIBELL. Since 2005 Veiga directs […]
Manel Esteller, International Research Award of Fundación Dexeus, Women’s Health
Manel Esteller, director of the Epigenetics and Cancer Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor has been awarded with the International Research Award of Fundación Dexeus, Women’s Health in its eighth edition. The award honors a person whose career and continuing line of research constitutes a […]